Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.

Saved in:
Bibliographic Details
Title: Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.
Authors: Blazejak, Christoph1 (AUTHOR), Oymanns, Mathias1,2 (AUTHOR), Stranzenbach, René2,3 (AUTHOR), Hillen, Uwe4,5 (AUTHOR), Mitteldorf, Christina5,6 (AUTHOR), Nicolay, Jan P.6,7 (AUTHOR), Wobser, Marion7,8 (AUTHOR), Schrüfer, Philipp8,9 (AUTHOR), Gosmann, Janika9,10 (AUTHOR), Wehkamp, Ulrike10,11,12,13 (AUTHOR), Booken, Nina11,14 (AUTHOR), Kreuter, Alexander12,15 (AUTHOR), Dippel, Edgar13,16 (AUTHOR), Klemke, Claus-Detlev14,17 (AUTHOR), Weyermann, Maria15,18 (AUTHOR), Stadler, Rudolf10,16 (AUTHOR), Assaf, Chalid1,17,19,20 (AUTHOR) chalid.assaf@helios-gesundheit.de
Source: Cancers. Jan2026, Vol. 18 Issue 1, p97. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first